All Access Articles |
- Tango Therapeutics Appoints Veteran Oncology Executive | 2026-06-24 | PHARMACEUTICAL
- Tango Therapeutics Achieves 92% Response Rate in Pancreatic Cancer | 2026-06-08 | PHARMACEUTICAL
- Tango Therapeutics Appoints New Executives | 2026-04-15 | UNITED STATES
- Tango Therapeutics Reports $343 Million Cash Position | 2026-03-05 | UNITED STATES